In addition, in order to evaluate the prognostic value of Spondin-2 in different subgroups, patients were stratified according to tumor size (Figure 4B, 4C), depth of invasion (Figure 4D, 4E), and lymph node metastasis (Figure 4F, 4G). Here, SPON2 is linked to neoplasm.